Inhibition of bacterial cell wall-induced leukocyte recruitment and hepatic granuloma formation by TGF-β gene transfer

Journal of Immunology

Volumn 163, Issue 7, 1999, Pages 4020-4026

  Song, Xiao Yu ^a   Zeng, Li ^a   Pilo, Carey M ^a   Zagorski, John ^a   Wahl, Sharon M ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CHEMOKINE; BETA CHEMOKINE; CYTOKINE; GAMMA INTERFERON; GROWTH FACTOR; INTERLEUKIN 18; INTERLEUKIN 1BETA; PLASMID DNA; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BACTERIAL CELL WALL; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FEMALE; GENE TRANSFER; KUPFFER CELL; LIVER FIBROSIS; LIVER GRANULOMA; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOCOCCUS; T LYMPHOCYTE;

ANIMALS; CELL MOVEMENT; CELL WALL; CYTOKINES; DNA; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GENE TRANSFER TECHNIQUES; GRANULOMA; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, INTRAMUSCULAR; INJECTIONS, INTRAPERITONEAL; LEUKOCYTES; LIVER DISEASES; RATS; RATS, INBRED LEW; RNA, MESSENGER; STREPTOCOCCUS PYOGENES; TRANSFORMING GROWTH FACTOR BETA;

EID: 0033214547     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Wahl, S. M., M. Frazier-Jessen, W. W. Jin, B. J. Kopp, A. Sher, and A. W. Cheever. 1997. Cytokine regulation of schistosome-induced granuloma and fibrosis. Kidney Int. 51:1370.
2. Bedossa, P., and V. Paradis. 1995. Transforming growth factor-β (TGF-β): a key role in liver fibrogenesis. J. Hepatol. 22:37.
3. Castilla, A., J. Prieto, and N. Fausto. 1991. Transforming growth factors β1 and a in chronic liver disease: effects of interferon α therapy. N. Engl. J. Med. 324: 933.
4. Nagy, P., Z. Schaff, and K. Lapis. 1991. Immunohistochemical detection of transforming growth factor-β1 in fibrotic liver diseases. Hepatology 14:269.
5. Annoni, G., F. R. Weiner, and M. A. Zern. 1992. Increased transforming growth factor-β1 gene expression in human liver disease. J. Hepatol. 14:259.
6. Border, W. A., and N. A. Noble. 1997. TGF-β in kidney fibrosis: a target for gene therapy. Kidney Int. 51:1388.
7. Border, W.A., and E. Ruoslahti. 1992. Transforming growth factor-β in disease: the dark side of tissue repair. J. Clin. Invest. 90:1.
8. Roberts, A. B., B. K. McCune, and M. B. Sporn. 1992. TGF-β: regulation of extracellular matrix. Kidney Int. 41:557.
9. Sanderson, N., V. Factor, P. Nagy, J. Kopp, P. Kondaiah, L. Wakefield, A. B. Roberts, M. B. Sporn, and S. S. Thorgeirsson. 1995. Hepatic expression of mature transforming growth factor β1 in transgenic mice results in multiple tissue lesions. Proc. Natl. Acad. Sci. USA 92:2572.
10. Clouthier, D. E., S. A. Comerford, and R. E. Hammer. 1997. Hepatic fibrosis, glomerulosclerosis, and a lipodystrophy-like syndrome in PEPCK-TGF-β1 transgenic mice. J. Clin. Invest. 100:2697.
11. Manthey, C. L., T. Kossmann, J. B. Allen, M. L. Corcoran, M. E. Brandes, and S. M. Wahl. 1992. Role of Kupffer cells in developing streptococcal cell wall granulomas: streptococcal cell wall induction of inflammatory cytokines and mediators. Am. J. Pathol. 140:1205.
12. Kossmann, T., C. L. Manthey, M. E. Brandes, M. C. Morganti-Kossmann, K. Ohura., J. B. Allen, S. E. Mergenhagen, and S. M. Wahl. 1992. Kupffer cells express type I TGF-β receptors, migrate to TGF-β and participate in streptococcal cell wall induced hepatic granuloma formation. Growth Factors 7:73.
13. Wahl, S. M., D. A. Hunt, J. B. Allen, R. L. Wilder, L. Paglia, and A. R. Hand. 1986. Bacterial cell wall-induced hepatic granulomas: an in vivo model of T-cell dependent fibrosis. J. Exp. Med. 163:884.
14. Wahl, S. M. 1988. Hepatic granuloma as a model of inflammation and repair: an overview. Methods Enzymol. 163:605.
15. Bissell, D. M. 1998. Hepatic fibrosis as wound repair: a progress report. J. Gastroenterol. 33:295.
16. Song, X-y, M. L. Gu, W. W. Jin, D. M. Klinman, and S. M. Wahl. 1998. Plasmid DNA encoding transforming growth factor β1 suppresses chronic disease in a streptococcal cell wall-induced arthritis model. J. Clin. Invest. 101:2615.
17. Hines, K. L., M. Christ, and S. M. Wahl. 1993. Cytokine regulation of the immune response: an in vivo model. Immunomethods. 3:13.
18. Jaskiewicz, K., L. Banach, and E. Lancaster. 1997. Hepatic siderosis, fibrosis and cirrhosis: the association with hepatocellular carcinoma in high-risk population. Anticancer Res. 17:3897.
19. Chadderton, T., C. Wilson, M. Bewick, and S. Gluck. 1997. Evaluation of three rapid RNA extraction reagents: relevance for use in RT-PCR's and measurement of low level gene expression in clinical samples. Cell. Mol. Biol. 43:1227.
20. Manthey, C. L., J. B. Allen, L. R. Ellingworth, and S. M. Wahl. 1990. In situ expression of transforming growth factor β in streptococcal cell wall-induced granulomatous inflammation and hepatic fibrosis. Growth Factors 4:17.
21. Wahl, S. M. 1988. Fibrosis: bacterial-cell-wall-induced hepatic granulomas. In Inflammation: Basic Principals and Clinical Correlates. J. I. Gallin, I. M. Goldstein, and R. Snyderman, eds. Raven Press, New York, p. 841.
22. Wahl, S. M. 1994. Transforming growth factor β: the good, the bad, and the ugly. J. Exp. Med. 180:1587.
23. Wahl, S. M. 1992. Transforming growth factor-β in inflammation: a cause and a cure. J. Clin. Immunol. 12:1.
24. McCartney-Francis, N. L., M. Frazier-Jessen, and S. M. Wahl. 1998. TGF-β: a balancing act. Intern. Rev. Immunol. 16:553.
25. Kopp, J. B., V. M. Factor, M. Mozes, P. Nagy, N. Sanderson, E. P. Bottinger, P. E. Klotman, and S. S. Thorgeirsson. 1996. Transgenic mice with increased plasma levels of TGF-β1 develop progressive renal disease. Lab. Invest. 74:991.
26. Sime, P. J., Z. Xing, F. L. Graham, K. G. Csaky, and J. Gauldie. 1997. Adenovector-mediated gene transfer of active transforming growth factor-β1 induces prolonged severe fibrosis in rat lung. J. Clin. Invest. 100:768.
27. Baggiolini, M., B. Dewald, and B. Moser. 1997. Human chemokines: an update. Annu. Rev. Immunol. 15:675.
28. Baggiolini, M. 1998. Chemokines and leukocyte traffic. Nature 392:565.
29. Lu, B., B. J. Rutledge, L. Gu, J. Horillo, N. W. Lukacs L. Kunkel, R. North, C. Gerard, and B. J. Rollins. 1998. Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J. Exp. Med. 187:601.
30. Kuziel, W. A., S. J. Morgan, T. C. Dawson, S. Griffin, O. Smithies, K. Ley, and N. Maeda. 1997. Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. Proc. Natl. Acad. Sci. USA 94:12053.
31. Kurihara, T., G. Wan, J. Loy, and R. Bravo. 1997. Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor. J. Exp. Med. 186:1757.
32. Marra, F., A. J. Valente, M. Pinani, and H. E. Abboud. 1993. Cultured human liver fat-storing cells produce monocyte chemotactic protien-1: regulation by proinflammatory cytokines. J. Clin. Invest. 92:1674.
33. Gerritsma, J. S., C. van Kooten, A. F. Gerritsen, L. A. van Es, and M. R. Daha. 1998. TGF-β regulates chemokine and complement production by human proximal tubular epithelial cells. Kidney Int. 53:609.
34. Kitamura, M. 1997. Identification of an inhibitor targeting macrophage production of monocyte chemoattractant protein-1 as TGF-β1. J. Immunol. 159:1404.
35. Maher, J. J., J. S. Lozier, and M. K. Scott. 1998. Rat hepatic stellate cells produce cytokine-induced neutrophil chemoattractant in culture and in vivo. Am. J. Physiol. 275:G847.
36. Brandes, M. E., J. B. Allen, Y. Ogawa, and S. M. Wahl. 1991. Transforming growth factor β1 suppresses acute and chronic arthritis in experimental animals. J. Clin. Invest. 37:1108.
37. Chen, W. J., W. W. Jin, M. Cook, H. L. Weiner, and S. M. Wahl. 1998. Oral delivery of group A streptococcal cell walls augments circulating TGF-β and suppresses streptococcal cell wall arthritis. J. Immunol. 161:6297.
38. Davis, B. H., U. R. Rapp, and N. O. Davidson. 1991. Retinoic acid and transforming growth factor beta differentially inhibit platelet-derived-growth-factor-induced Ito-cell activation. Biochem. J. 278:43.
39. Wahl, S. M., D. A. Hunt, L. Wakefield, N. McCartney-Francis, L. M. Wahl, A. B. Roberts, and M. B. Sporn. 1987. Transforming growth factor β (TGF-β) induces monocyte chemotaxis and growth factor production. Proc. Natl. Acad. Sci. USA 84:5788.
40. Knittel, T., M. Mehde, D. Kobold, B. Saile, C. Dinter, and G. Ramadori. 1999. Expression patterns of matrix metalloproteinases and their inhibitors in parenchymal and non-parenchymal cells of rat liver: regulation by TNF-α and TGF-β1. Hepatology 30:48.
41. Wahl, S. M., J. B. Allen, B. S. Weeks, H. L. Wong, and P. E. Klotman. 1993. Transforming growth factor β enhances integrin expression and type IV collagenase secretion in human monocytes. Proc. Natl. Acad. Sci. USA 90:4577.
42. Pierce, G. F., T. A. Mustoe, J. Lingelbach, V. R. Masakowski, G. L. Griffin, R. M. Senior, and T. F. Deuel. 1989. Platelet-derived growth factor and transforming growth factor-α enhance tissue repair activities by unique mechanisms. J. Cell Biol. 109:429.
43. Ankoma-Sey, V., M. Math, K. B. Chang, A. Lalazar, D. B. Donner, L. Wong, R. S. Warren, and S. L. Friedman. 1998. Coordinated induction of VEGF receptors in mesenchymal cell types during rat hepatic wound healing. Oncogene 17: 115.
44. Wempe, F., V. Lindner, and H. G. Augustin. 1997. Basic fibroblast growth factor (bFGF) regulates the expression of the CC chemokine monocyte chemoattractant protein-1 (MCP-1) in autocrine-activated endothelial cells. Arterioscler. Thromb. Vasc. Biol. 17:2471.